The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA. The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA. | | |
|
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care. Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care. | | |
|
Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic. Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic. | | |
|
Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred. Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred. | | |
|
|
Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject. Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject. | | |
|
Field Medical, founded in 2022 by Steven Mickelsen, MD, is set to make a significant splash at the Heart Rhythm Society's annual meeting in San Diego. The company also just raised $40 million in financing. Field Medical, founded in 2022 by Steven Mickelsen, MD, is set to make a significant splash at the Heart Rhythm Society's annual meeting in San Diego. The company also just raised $40 million in financing. | | |
|
Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic's Evolut TAVR platform performs as well as SAVR—and even better in some ways. Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic's Evolut TAVR platform performs as well as SAVR—and even better in some ways. | | |
|
Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership. Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership. | | |
|
|
TAVR is being used in more patients to treat severe aortic stenosis. However, according to a new commentary piece, SAVR is still the smartest treatment option for certain populations, including younger patients with bicuspid aortic valves. TAVR is being used in more patients to treat severe aortic stenosis. However, according to a new commentary piece, SAVR is still the smartest treatment option for certain populations, including younger patients with bicuspid aortic valves. | | |
|
The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair. The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair. | | |
|
SCAI President James B. Hermiller, Jr., MD, detailed the group's key policy concerns in 2025 and beyond in a new video interview. SCAI President James B. Hermiller, Jr., MD, detailed the group's key policy concerns in 2025 and beyond in a new video interview. | | |
|
|
Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence. Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence. | | |
|
The Florida governor claims the money was not part of a settlement the state made with Centene, and that the insurer donated the cash as a “cherry on top.” The Florida governor claims the money was not part of a settlement the state made with Centene, and that the insurer donated the cash as a “cherry on top.” | | |
|
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
